TMCnet News
SHAREHOLDER ALERT: Labaton Sucharow Investigates Claims On Behalf of Investors of Athenex, Inc. (NASDAQ: ATNX)Labaton Sucharow, a nationally ranked and award-winning shareholder rights firm, is investigating potential securities violations and breach of fiduciary duty claims against Athenex, Inc. (NASDAQ: ATNX). Shares are down over 50% after the Company reported Q4 results and received a complete response letter from the FDA regarding its new drug application for oral paclitaxel plus encequidar for the treatment of metastatic breast cancer. The FDA expressed the following:
About the Firm Labaton Sucharow LLP is one of the world's leading complex litigation firms representing clients in securities, antitrust, corporate governance and shareholder rights, and consumer cybersecurity and data privacy litigation. Labaton Sucharow has been recognized for its excellence by the courts and peers, and it is consistently ranked in leading industry publications. Offices are located in New York, NY, Wilmington, DE, and Washington, D.C. More information about Labaton Sucharow is available at http://www.labaton.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210301005719/en/ |